期刊文献+

恶性肿瘤患者血栓的形成机制与诊断进展 预览 被引量:11

在线阅读 下载PDF
分享 导出
摘要 随着肿瘤发病率的不断增高,恶性肿瘤的高凝状态也日趋突出,血栓形成的风险也明显增加,往往是恶性肿瘤的最早临床表现之一。肿瘤患者血栓形成机制除与肿瘤本身的因素有关外,还与肿瘤的治疗有一定关系,其诊断方法主要为实验室诊断及相关仪器检查。本文主要从恶性肿瘤患者血栓形成机制及诊断2个方面进行综述,旨在引起广大医师的重视,为肿瘤合并血栓形成患者的及时诊断、干预提供帮助。
作者 陈国荣
出处 《新乡医学院学报》 CAS 2015年第9期891-893,共3页 Journal of Xinxiang Medical College
基金 河南省医学科技攻关计划项目(编号:201203076)
关键词 肿瘤 血栓 诊断
作者简介 陈国荣(1966-),女,河南浚县人,硕士,主任医师,研究方向:恶性肿瘤诊断与综合治疗。
  • 相关文献

参考文献20

  • 1赵晶,姜达.恶性肿瘤高凝状态及其干预[J].癌症进展,2013(1):48-52. 被引量:28
  • 2王绍霞.恶性肿瘤并发静脉血栓的原因分析及防治干预.中医学报,2010,:622-623. 被引量:4
  • 3李君艳,张永喜,陈国荣.恶性肿瘤合并下肢深静脉血栓形成13例[J].肿瘤研究与临床,2012,24(5):334-335. 被引量:3
  • 4Ahbrecht J,Dickmann B,Ay C,et al.Tumor grade is associated with venous thromboembolism in patients with cancer:results from the Vienna Cancer and Thrombosis Study[J].J Clin Oncol,2012,30(31):3870-3875. 被引量:1
  • 5Bluff J E,Brown N J,Reed M W,et al.Tissue factor,angiogenesis and tumour progression[J].Breast Cancer Res,2008,10(2):204. 被引量:1
  • 6Yokota N,Koizume S,Miyagi E,et al.Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells[J].Br J Cancer,2009,101(12):2023-2029. 被引量:1
  • 7Noble S I,Shelley M D,Coles B,et al.Management of venous thromboembolism in patients with advanced cancer:a systematic review and meta-analysis[J].Lancet Oncol,2008,9(6):577-584. 被引量:1
  • 8Noble S,Pasi J.Epidemiology and pathophysiology of cancer-associated thrombosis[J].Br J Cancer,2010,102(Suppl 1):S2-S9. 被引量:1
  • 9Schreiber D P,Kapp D S.Axillary-subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma[J].Int J Radiat Oncol Biol Phys,1986,12(3):391-395. 被引量:1
  • 10Cronin-Fenton D P,Sondergaard F,Pedersen L A,et al.Hospitalisation for venous thromboembolism in cancer patients and the general population:a population-based cohort study in Denmark,1997-2006[J].Br J Cancer,2010,103(7):947-953. 被引量:1

二级参考文献64

共引文献66

同被引文献100

  • 1孟庆海,薄勇力,李洛,宫安静.树突状细胞疫苗治疗大鼠脑胶质瘤的实验研究[J].中华神经外科杂志,2006,22(1):55-58. 被引量:14
  • 2朱萍娅,吴白平.肺癌患者凝血功能4项指标变化及临床意义[J].实用预防医学,2007,14(5):1578-1579. 被引量:5
  • 3曹漫明,吴钢,汪森明,张积仁.脑胶质瘤化疗研究进展[J].中华神经医学杂志,2007,6(11):1177-1180. 被引量:5
  • 4Anand M, Brat DJ. Oncogenic regulation of tissue factor and thrombo- sis in cancerE J]. Thromb Res, 2012, 129 Suppl 1 : $46-$49. DOI: 10. 1016/S0049-3848 ( 12)700154. 被引量:1
  • 5Grane CA, Han SJ, Barry JJ, et al. TGF-beta downregulates the acti- vating receptor NKG2D on NK cells and CD8 * T cells in glioma pa- tients[J]. Neuro Oncol, 2010, 12(1): 7-13. DOI: 10. 1093/ neuonc/nop009. 被引量:1
  • 6Gigante M, Gesualdo L, Ranieri E. TGF-beta: a master switch in tumor immunity[J~. Curt Pharm Des, 2012, 18(27) : 4126-4134. 被引量:1
  • 7Van den Berg YW, Osanto S, Reitsma PH, et al. The relationship between tissue factor and cancer progression : insights from bench and bedside~J]. BIood, 2012, 119 (4): 924-932. DOI: 10. 1182/ blood-2011-06-317685. 被引量:1
  • 8Godby RC, van den Berg YW, Srinvasan RS, et al. Non-proteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models [ J ]. Mol Med, 2012, 18(1) : 771-779. DOI: lO.2119/rnolmed. 2011.O0416. 被引量:1
  • 9Srinivasan R, (~zhegov E, van den Berg YW, et al. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signa- ling[J]. Thromb Haemost, 2011, 9( 10): 2087-2096. DOI: 10. 1111/j. 1538-7836.2011. 04454. 被引量:1
  • 10Ettelaie C, Collier ME, Mei MP, et al. Enhanced binding of tissue factor microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro [ J ]. Thromb Haemost, 2013, 109 (1) : 61-71. DOI: 10. 1160/TH12-05-0279. 被引量:1

引证文献11

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈